India's Serum Institute seeks approval to make Russia's Sputnik V vaccine -local media
- 3 years ago
The Serum Institute of India (SII) has sought regulatory approval to make Russia's Sputnik V COVID-19 vaccine, two sources said on Thursday, joining a clutch of drugmakers in the country that are already expected to make around 1 billion doses annually.
SII, the world's biggest vaccine producer, is already making the AstraZeneca PLC (AZN.L) and Novavax vaccines in India.
The company has now sought preliminaryapproval from the federal drug regulator for making Sputnik V, the sources said, declining to be identified as details of the application have not been made public.
The drug regulator and SII did not immediately respond to a Reuters e-mail seeking comment.
Comments